{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:51:24Z","timestamp":1793379084293,"version":"4.5.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["1R35CA210039"],"award-info":[{"award-number":["1R35CA210039"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["5UL1TR000005"],"award-info":[{"award-number":["5UL1TR000005"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA200466"],"award-info":[{"award-number":["U01 CA200466"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["UO1 CA152753"],"award-info":[{"award-number":["UO1 CA152753"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01401","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T13:02:31Z","timestamp":1560949351000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":101,"title":["Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer"],"prefix":"10.3389","volume":"10","author":[{"given":"Peiwen","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Beatty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McKolanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randal","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Schoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera J.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17111","DOI":"10.1073\/pnas.1108121108","article-title":"Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model","volume":"108","author":"Meyer","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jaut.2017.07.010","article-title":"Myeloid suppressor cells in cancer and autoimmunity","volume":"85","author":"Sica","year":"2017","journal-title":"J Autoimmun"},{"key":"B3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/ddg.12411","article-title":"Myeloid-derived suppressor cells in malignant melanoma","volume":"12","author":"Umansky","year":"2014","journal-title":"J Dtsch Dermatol Ges"},{"key":"B6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bbrc.2013.04.109","article-title":"HMGB1 recruits myeloid derived suppressor cells to promote peritoneal dissemination of colon cancer after resection","volume":"436","author":"Li","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1002\/eji.201040895","article-title":"The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity","volume":"40","author":"Youn","year":"2010","journal-title":"Eur J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/cgt.2016.65","article-title":"Myeloid-derived suppressor cells and their role in pancreatic cancer","volume":"24","author":"Pergamo","year":"2017","journal-title":"Cancer Gene Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2047-1440-1-15","article-title":"Generation of myeloid-derived suppressor cells using prostaglandin E2","volume":"1","author":"Obermajer","year":"2012","journal-title":"Transplant Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1093\/emboj\/cdf478","article-title":"Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals","volume":"21","author":"Eliopoulos","year":"2002","journal-title":"EMBO J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"G196","DOI":"10.1152\/ajpgi.00495.2012","article-title":"Induction of COX-2 expression by Helicobacter pylori is mediated by activation of epidermal growth factor receptor in gastric epithelial cells","volume":"305","author":"Sierra","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/carcin\/bgr027","article-title":"Macrophages induce COX-2 expression in breast cancer cells: role of IL-1\u03b2 autoamplification","volume":"32","author":"Hou","year":"2011","journal-title":"Carcinogenesis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1158\/0008-5472.CAN-12-4124","article-title":"GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-\u03b1","volume":"73","author":"Kohanbash","year":"2013","journal-title":"Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1084\/jem.20050715","article-title":"Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma","volume":"202","author":"Rodriguez","year":"2005","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.1158\/0008-5472.CAN-11-2449","article-title":"PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment","volume":"71","author":"Obermajer","year":"2011","journal-title":"Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0016-5085(98)70132-5","article-title":"Is colonoscopy needed for the nonadvanced adenoma found on sigmoidoscopy?","volume":"115","author":"Schoen","year":"1998","journal-title":"Gastroenterology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1053\/j.gastro.2012.06.001","article-title":"Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer","volume":"143","author":"Lieberman","year":"2012","journal-title":"Gastroenterology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.vaccine.2006.11.007","article-title":"MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model","volume":"25","author":"Mukherjee","year":"2007","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1158\/1940-6207.CAPR-12-0275","article-title":"MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study","volume":"6","author":"Kimura","year":"2013","journal-title":"Cancer Prev Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1001\/jama.2018.5809","article-title":"Association of colonoscopy adenoma findings with long-term colorectal cancer incidence","volume":"319","author":"Click","year":"2018","journal-title":"JAMA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00262-016-1838-1","article-title":"Immunobiology and immunosurveillance in patients with intraductal papillary mucinous neoplasms (IPMNs), premalignant precursors of pancreatic adenocarcinomas","volume":"65","author":"Beatty","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"B24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12026-011-8214-1","article-title":"Importance of MUC1 and spontaneous mouse tumor models for understanding the immunobiology of human adenocarcinomas","volume":"50","author":"Finn","year":"2011","journal-title":"Immunol Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1182\/blood-2011-07-365825","article-title":"Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells","volume":"118","author":"Obermajer","year":"2011","journal-title":"Blood"},{"key":"B26","first-page":"4756","article-title":"Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients","volume":"61","author":"Schmielau","year":"2001","journal-title":"Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3389\/fimmu.2017.01895","article-title":"Monocytic myeloid-derived suppressor cells in chronic infections","volume":"8","author":"Dorhoi","year":"2017","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/abbs\/gmy014","article-title":"Myeloid-derived suppressor cells suppress CD4+ T cell activity and prevent the development of type 2 diabetes","volume":"50","author":"Wang","year":"2018","journal-title":"Acta Biochim Biophys Sin"},{"key":"B29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1158\/1940-6207.CAPR-09-0194","article-title":"Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer","volume":"3","author":"Beatty","year":"2010","journal-title":"Cancer Prev Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma","volume":"369","author":"Hamid","year":"2013","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.coi.2012.12.003","article-title":"T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment","volume":"25","author":"Crespo","year":"2013","journal-title":"Curr Opin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01401\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T09:10:33Z","timestamp":1569402633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01401\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,19]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2019.01401"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01401","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,19]]},"article-number":"1401"}}